Review ArticleReview Article
Open Access

Prostate cancer in the Arab population

An overview

Osman Z. Al-Abdin and Ibrahim Z. Al-Beeshi
Saudi Medical Journal May 2018, 39 (5) 453-458; DOI: https://doi.org/10.15537/smj.2018.5.21986

References

  1. ↵
    1. Fitzmaurice C,
    2. Allen C,
    3. Barber R
    (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015. JAMA Oncol 3:524.
    OpenUrl
  2. ↵
    1. Mosli HA
    (2003) Prostate cancer in Saudi Arabia in 2002. Saudi Med J 24:573–581.
    OpenUrlPubMed
  3. ↵
    1. Bener A,
    2. Ayub H,
    3. Kakil R,
    4. Ibrahim W
    (2008) Patterns of cancer incidence among the population of Qatar: a worldwide comparative study. Asian Pac J Cancer Prev 9:19–24.
    OpenUrlPubMed
  4. ↵
    1. National Cancer Institute
    SEER Program. Cancer Stat Facts: Prostate, Available from: http://seer.cancer.gov/statfacts/html/prost.html. [cited 22 March 2015].
  5. ↵
    1. Keetch DW,
    2. Humphery PA,
    3. Smith DS,
    4. Stahl D,
    5. Catalona WJ
    (1996) Clinical and pathological feature of hereditary prostate cancer. J Urol 155:1841–1843.
    OpenUrlCrossRefPubMed
  6. ↵
    1. McLellan DL,
    2. Norman RW
    (1995) Hereditary aspects of prostate cancer. Can Med Assoc J 153:895–900.
    OpenUrlAbstract
  7. ↵
    1. Kehinde EO
    (2005) Age-specific reference levels of serum prostate-specific antigen and prostate volume in healthy Arab men 2005. BJU Int 96:308–312.
    OpenUrlPubMed
  8. ↵
    1. Kehinde EO
    (2006) Do differences in age specific androgenic steroid hormone levels account for differing prostate cancer rates between Arabs and Caucasians? Int J Urol 13:354–361.
    OpenUrlPubMed
  9. ↵
    1. National Cancer Registry
    (2001) Cancer incidence in Saudi Arabia 1997-1998 report (Ministry of Health, Riyadh (KSA)).
  10. ↵
    1. Alyaiya AA
    (2011) Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma. Int J Oncol 38:1047–1057.
    OpenUrlPubMed
  11. ↵
    1. Zeigler-Johnson C,
    2. Walker A,
    3. Mancke B,
    4. Spangler E,
    5. Jalloh M,
    6. McBride S,
    7. et al.
    (2002) Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4. Hum Heredity 54:13–21.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Li J,
    2. Mercer E,
    3. Gou X,
    4. Lu YJ
    (2013) Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes. Am J Cancer Res 3:127–151.
    OpenUrlPubMedWeb of Science
  13. ↵
    1. Giovannucci E,
    2. Stampfer MJ,
    3. Krithivas K,
    4. Brown M,
    5. Dahl D,
    6. Brufsky A,
    7. et al.
    (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94:3320–3323.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Hamalainen E,
    2. Adlercreutz H,
    3. Puska P,
    4. Pietinen P
    (1984) Diet and serum sex hormones in healthy men. J Steroid Biochem 20:459–464.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Rabah DM,
    2. Arafa MA
    (2010) Prostate cancer screening in Saudi population: an explanatory trial study. Prostate Cancer Prostatic Dis 13:191–194.
    OpenUrlPubMed
  16. ↵
    1. Hemminki K,
    2. Li X,
    3. Czene K
    (2002) Cancer risks in first-generation immigrants to Sweden. Int J Cancer 99:218–228.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Visser O,
    2. van Leeuwen FE
    (2007) Cancer risk in first generation migrants in North-Holland/Flevoland, The Netherlands 1995-2004. Eur J Cancer 43:901–908.
    OpenUrlPubMed
  18. ↵
    1. Nasseri K,
    2. Mills P,
    3. Allan A
    (2007) Cancer incidence in the Middle Eastern population of California 1988-2004. Asian Pac J Cancer Prev 8:405–411.
    OpenUrlPubMed
  19. ↵
    1. Grulich AE,
    2. McCredie M,
    3. Coates M
    (1995) Cancer incidence in Asian migrants to New South Wales, Australia. Br J Cancer 71:400–408.
    OpenUrlPubMedWeb of Science
  20. ↵
    1. Hanash K,
    2. Al-Othaimeen A,
    3. Kattan S,
    4. Lindstedt E,
    5. Al-Zahrani H
    (2000) Prostatic carcinoma: a nutritional disease? Conflicting data from the Kingdom of Saudi Arabia. J Urol 164:1570–1572.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Kehinde EO
    (2006) Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men. Int Urol Nephrol 38:33–44.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Schroder FH
    (2010) Prostate cancer around the world. An overview. Semin Orig Invest 28:663–667.
    OpenUrl
  23. ↵
    1. Arafa M,
    2. Rabah D
    (2017) With increasing trends of prostate cancer in the Saudi Arabia and Arab world: should we start screening programs? World J Clin Oncol 8:447–449.
    OpenUrl
  24. ↵
    1. Arafa MA,
    2. Rabah DM,
    3. Abdel-Gawad E,
    4. Ibrahim FK
    (2010) Association of physicians'knowledge and behavior with prostate cancer counseling and screening in Saudi Arabia. Saudi Med J 31:1245–1250.
    OpenUrlPubMed
  25. ↵
    1. Kehinde EO
    (2003) High serum prostate-specific antigen levels in the absence of prostate cancer in Middle-Eastern men: the clinician's dilemma. BJU Int 91:618–622.
    OpenUrlPubMed
  26. ↵
    1. Sheikh M,
    2. Al-Saeed O,
    3. Kehinde EO,
    4. Sinan T,
    5. Anim JT,
    6. Ali Y
    (2005) Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men. Int Urol Nephrol 37:721–726.
    OpenUrlPubMed
  27. ↵
    1. Kamal BA
    (2003) Prostate specific antigen reference ranges in Saudi men. Saudi Med J 24:665–668.
    OpenUrlPubMed
    1. Tamimi W
    (2010) Complexed and total PSA in patients with benign prostatic hyperplasia and prostate cancer. Br J Biomed Sci 67:184–188.
    OpenUrlPubMed
  29. ↵
    1. Hekal IA
    (2009) The patients less than 50 years: is there a need to lower the PSA cutoff point? Prostate Cancer Prostatic Dis 12:148–151.
    OpenUrlPubMed
  30. ↵
    1. IARC, WHO
    Prostate Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012, Available from URL: http://globocan.iarc.fr/old/FactSheets/cancers/prostate-new.asp. [Accessed 2018 March 5].
  31. ↵
    1. IARC, WHO
    Prostate Cancer: Frequency Worldwide in 2012, Available from URL: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. [Accessed 2018 March 5].
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section